DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Orciprenaline
Orciprenaline
PRODUCT MONOGRAPH ORCIPRENALINE Orciprenaline Sulphate Syrup House Standard 2 Mg/Ml Β2-Adrenergic Stimulant Bronchodilator AA P
Us Anti-Doping Agency
ADD/ADHD: Strattera • Allergy/Anti-Inflammatories
Etats Rapides
Clinical Trial of Orciprenaline in Bradyarrhythmias
Orciprenaline Sulphate (Alupent): Planned Withdrawal from the UK Market Following a Risk-Benefit Analysis
UV-Vis-5-Compressed.Pdf
(12) Patent Application Publication (10) Pub. No.: US 2015/0202317 A1 Rau Et Al
(12) United States Patent (10) Patent No.: US 9,376.418 B2 Haidle Et Al
Marrakesh Agreement Establishing the World Trade Organization
Drug Index and Glossary
Pharmacology and Therapeutics of Bronchodilators
WO 2008/150493 Al
Medicines and Related Substances Act No. 101 of 1965
Bronchodilator and Cardiac Effects of Isoprenaline, Orciprenaline, and Salbutamol Aerosols in Asthma A
Management of Asthma in Athletes Michael G
A Computational Tool for Pathway-Based Rational Drug Repositioning Supplementary Information
Medicines and Related Substances Act No 101 of 1965, As Amended
Top View
Supplementary Material A: RECORD Statement
Stembook 2018.Pdf
Drug/Substance Trade Name(S)
United States Patent (10) Patent No.: US 9,605,003 B2 Castro Et Al
Supplementary File
PRODUCT MONOGRAPH Pr SANDOZ SALBUTAMOL (Salbutamol Sulfate Inhalation Solution) 0.5% 5 Mg/Ml Bronchodilator Beta2-Adrenergic
Council of Europe Committee of Ministers (Partial
Inhalation Composition Containing Aclidinium for Treatment of Asthma and Chronic Obstructive Pulmonary Disease
Asthma and Exercise-Induced Respiratory Disorders in Athletes. the Position Paper of the Polish Society of Allergology and Polish Society of Sports Medicine
Striving for Optimal Bronchodilation: Focus on Olodaterol
Examples of Prohibited and Permitted Substances And
2019 Equine Prohibited Substances List
Inhalation Composition Containing Aclidinium for Treatment of Asthma and Chronic Obstructive Pulmonary Disease
Indian Science Congress, Part II : Presidential Address
Palu Ent ~~Orciprenaline
WO 2016/161086 Al 6 October 2016 (06.10.2016) P O P C T
Customs Tariff - Schedule Xxi - 1
Drug Index and Glossary
New Substituted Indolin-2-One Derivatives and Their Use As P39
WALLET CARD2021 Examples of Prohibited and Permitted Substances and Methods Effective Jan
Toxicity Prediction Using Multi-Disciplinary Data Integration and Novel Computational Approaches
Striving for Optimal Bronchodilation: Focus on Olodaterol
Literature Search Strategy for Treatment of Stable
Solid Preparation
List of Drugs to Be Avoided by Patients with Congenital Long QT Syndrome
Alphabetical List of Pharmaceutical Products (PDF)
Inhaled Adrenergic Bronchodilators: Historical Development and Clinical Application
Harmonized Tariff Schedule of the United States (2006) (Rev
Illness Code A: Mental Handicap
R. G. SHANKS M.D., D.Sc
Chronic Obstructive Pulmonary Disease: Management of Adults with Chronic Obstructive Pulmonary Disease in Primary and Secondary Care
Mesh Terms for 2002
ICD-10-CM TABLE of DRUGS and CHEMICALS
List of New Drugs Approved in India from 1961 to 1970
Table of Drugs and Chemicals (FY12)
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Pharmaceutical Appendix to the Tariff Schedule 2
Investigation of Occurrence of Tolerance to Bronchodilator Drugs in Chronically Pretreated Guinea-Pigs A.A
Chirality of Β2-Agonists. an Overview of Pharmacological Activity, Stereoselective Analysis, and Synthesis
Bronchodilators in Asthma
ICD-10-CM Table of Drugs 2019
Ipratropium Bromide Monohydrate and Salbutamol Sulfate)
International Classification of Procedures in Medicine
WO 2011/012715 Al
Management of Severe COPD Exacerbations: Focus on Beclomethasone Dipropionate/ Formoterol/Glycopyrronium Bromide
Methods in Literature-Based Drug Discovery
(12) United States Patent (10) Patent No.: US 7,183.293 B2 Marfat Et Al
ATC) Codes and Drug Identification Numbers (Dins